Financhill
Sell
43

MXCHF Quote, Financials, Valuation and Earnings

Last price:
$0.76
Seasonality move :
-1.18%
Day range:
$0.76 - $0.76
52-week range:
$0.76 - $2.35
Dividend yield:
11.03%
P/E ratio:
10.65x
P/S ratio:
0.19x
P/B ratio:
0.55x
Volume:
--
Avg. volume:
911
1-year change:
-66.4%
Market cap:
$1.4B
Revenue:
$8.2B
EPS (TTM):
$0.07

Analysts' Opinion

  • Consensus Rating
    Orbia Advance Corp SAB de CV has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Downside
    According to analysts' consensus price target of --, Orbia Advance Corp SAB de CV has an estimated downside of -- from its current price of $0.76.
  • Price Target Upside
    According to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $0.76.

Fair Value

  • According to the consensus of 0 analysts, Orbia Advance Corp SAB de CV has -- downside to fair value with a price target of -- per share.

MXCHF vs. S&P 500

  • Over the past 5 trading days, Orbia Advance Corp SAB de CV has underperformed the S&P 500 by -1.77% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Orbia Advance Corp SAB de CV does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Orbia Advance Corp SAB de CV revenues have been falling on a year-over-year basis for 8 quarters in a row. In the most recent quarter Orbia Advance Corp SAB de CV reported revenues of $1.9B.

Earnings Growth

  • Orbia Advance Corp SAB de CV has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Orbia Advance Corp SAB de CV reported earnings per share of $0.05.
Enterprise value:
6.1B
EV / Invested capital:
0.74x
Price / LTM sales:
0.19x
EV / EBIT:
10.41x
EV / Revenue:
0.81x
PEG ratio (5yr expected):
0.31x
EV / Free cash flow:
22.14x
Price / Operating cash flow:
5.12x
Enterprise value / EBITDA:
8.14x
Gross Profit (TTM):
$1.7B
Return On Assets:
1.2%
Net Income Margin (TTM):
1.83%
Return On Equity:
4.32%
Return On Invested Capital:
1.67%
Operating Margin:
6.62%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Income Statement
Revenue $9.9B $8.5B $7.5B $2B $1.9B
Gross Profit $2.7B $2.3B $1.7B $497M $430M
Operating Income $1.5B $822M $475M $178M $125M
EBITDA $2B $1.3B $751M $358M $303M
Diluted EPS $0.37 $0.05 $0.07 $0.04 $0.05
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Balance Sheet
Current Assets $3.4B $3.6B $4.2B $4.5B $3.9B
Total Assets $10.4B $10.5B $11.1B $11.6B $11.5B
Current Liabilities $2.4B $2.6B $3B $2.7B $2.6B
Total Liabilities $7.4B $7.1B $7.9B $8.4B $8.3B
Total Equity $3.1B $3.3B $3.2B $3.3B $3.2B
Total Debt $4.2B $4B $4.7B $5.3B $5B
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Cash Flow Statement
Cash Flow Operations $1.1B $1.5B -- $347M $374M
Cash From Investing -$659.6M -$704M -- -$170M -$104M
Cash From Financing -$266.7M -$264M -- -$1M -$152M
Free Cash Flow $710.8M $867M $276M $165M $270M
MXCHF
Sector
Market Cap
$1.4B
$18.9M
Price % of 52-Week High
32.38%
57.66%
Dividend Yield
11.03%
0%
Shareholder Yield
5.84%
1.61%
1-Year Price Total Return
-66.4%
-18.53%
Beta (5-Year)
0.891
1.064
Dividend yield:
11.03%
Annualized payout:
$0.13
Payout ratio:
87.59%
Growth streak:
1 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Sell
Level $0.79
200-day SMA
Sell
Level $1.39
Bollinger Bands (100)
Sell
Level 0.86 - 1.1
Chaikin Money Flow
Sell
Level -3.7M
20-day SMA
Sell
Level $0.84
Relative Strength Index (RSI14)
Sell
Level 12.85
ADX Line
Neutral
Level
Williams %R
Buy
Level -100
50-day SMA
Sell
Level $0.89
MACD (12, 26)
Sell
Level -0.04
25-day Aroon Oscillator
Sell
Level -64
On Balance Volume
Sell
Level -8.8M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (1.4547)
Sell
CA Score (Annual)
Level (-1.0965)
--
Beneish M-Score (Annual)
Level (--)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (4.7603)
--
Piotroski F Score (Annual)
Level (--)
Buy
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (8)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Orbia Advance Corp SAB de CV manufactures and sells a variety of chemical-based products and energy. The firm's operating segments are included in five business groups: i) Building & Infrastructure (under the Wavin brand), ii) Data Communications (under the Dura-Line brand), iii) Precision Agriculture (under the Netafim brand), iv) Fluorinated Solutions (under the Koura brand), and v) Polymer Solutions (under the Vestolit and Alphagary brands). The majority of revenue comes from the USA and Europe.

Stock Forecast FAQ

In the current month, MXCHF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The MXCHF average analyst price target in the past 3 months is --.

  • Where Will Orbia Advance Corp SAB de CV Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Orbia Advance Corp SAB de CV share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About Orbia Advance Corp SAB de CV?

    Analysts are divided on their view about Orbia Advance Corp SAB de CV share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Orbia Advance Corp SAB de CV is a Sell and believe this share price will rise from its current level to --.

  • What Is Orbia Advance Corp SAB de CV's Price Target?

    The price target for Orbia Advance Corp SAB de CV over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is MXCHF A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Orbia Advance Corp SAB de CV is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of MXCHF?

    You can purchase shares of Orbia Advance Corp SAB de CV via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Orbia Advance Corp SAB de CV shares.

  • What Is The Orbia Advance Corp SAB de CV Share Price Today?

    Orbia Advance Corp SAB de CV was last trading at $0.76 per share. This represents the most recent stock quote for Orbia Advance Corp SAB de CV. Yesterday, Orbia Advance Corp SAB de CV closed at $0.76 per share.

  • How To Buy Orbia Advance Corp SAB de CV Stock Online?

    In order to purchase Orbia Advance Corp SAB de CV stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Will Airbnb Stock Go?
How High Will Airbnb Stock Go?

Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…

Why Is SoundHound AI Stock Up So Much?
Why Is SoundHound AI Stock Up So Much?

Like many companies improving AI technologies and exploring ways to…

Is The Santa Claus Rally The Gift That Keeps Giving?
Is The Santa Claus Rally The Gift That Keeps Giving?

Remember the horror of 2008 when the Great Recession hit…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 43x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Buy
57
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Alerts

Buy
64
ARQQ alert for Dec 27

Arqit Quantum [ARQQ] is up 49.85% over the past day.

Buy
64
QMCO alert for Dec 27

Quantum [QMCO] is up 49.62% over the past day.

Buy
65
ALGS alert for Dec 27

Aligos Therapeutics [ALGS] is up 10.88% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock